MIRA INFORM REPORT

 

 

Report Date :

24.06.2013

 

IDENTIFICATION DETAILS

 

Name :

UMANG PHARMATECH PRIVATE LIMITED

 

 

Registered Office :

Flat No. 34, 3rd Floor, B- 2 , Windermere, Off New Link Road, Andheri  (West), Mumbai  - 400053, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

18.05.1992

 

 

Com. Reg. No.:

11-066815

 

 

Capital Investment / Paid-up Capital :

Rs.30.100 Millions

 

 

CIN No.:

[Company Identification No.]

U29297MH1992PTC066815

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMU01759C

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturing of Various Kind of Pharmaceutical Machines and Formulation of Bulk Drugs etc.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (51)_

 

RATING

STATUS

 

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 383000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having a satisfactory track record. Even though the net sale has seen a drastic dip, the net profitability of the company ahs increases during 2012. The profit margin appears to be good.

 

Trade relations are reported to be fair. Business is active. Payment terms are usually correct.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

LOCATIONS

 

Registered / Head Office :

Flat No. 34, 3rd Floor, B- 2 , Windemere, Off New Link Road, Andheri  (West), Mumbai  - 400 053, Maharashtra, India

Tel. No.:

91-22-30018900 / 30018915-98

Fax No.:

91-22-40106464 / 30018908/ 30018907

E-Mail :

budhraja@umangpharmatech.com

uppl@bom5.vsnl.net.in 

sales@umangpharmatech.com

Website :

http://www.umangpharmatech.com

 

 

Main Office / Factory 1 :

Survey No. 146, H.No.1 (PT), Vasai Phata Highway Junction,  Pelhar, NH8, Vasai (East) - 401 208, Maharashtra, India

Tel. No.:

91-22-30018900 / 30018915 - 98

Fax No.:

91-22-30018908 / 30018913

E-mail:

info@umangpharmatech.com

 

 

Factory 2 :

Plot No. 23, Golani Complex, Opposite Agrwal Hospital, Valiv, Vasai Road (East), Thane-401208, Maharashtra, India

Tel. No.:

91-250-2453795/2454467/2456482

Fax No.:

91-250-2453795/2454467/2456482

 

 

DIRECTORS

 

AS ON 25.09.2012

 

Name :

Mr. Raj Kumar Budhraja

Designation :

Managing director

Address :

Flat No. 34, 3rd Floor, B- 2 , Windermere, Off New Link Road, Andheri  (West), Mumbai  - 400053, Maharashtra, India

Date of Birth/Age :

12.12.1946

Qualification :

B. E

Date of Appointment :

18.05.1992

DIN No.:

01847459

 

 

Name :

Mrs. Renu Rajkumar Budhraja

Designation :

Director

Address :

Flat No. 34, 3rd Floor, B- 2 , Windemere, Off New Link Road, Andheri  (West), Mumbai  - 400053, Maharashtra, India

Date of Birth/Age :

05.03.1954

Date of Appointment :

18.05.1992

DIN No.:

01114263

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 25.09.2012

 

Names of Shareholders

 

No. of Shares

Rajkumar Budhraja

 

140000

Renu Rajkumar Budhraja

 

140000

Priya Komal Narang

 

7000

Umang Rajkumar Budhraja

 

7000

Payal Rajkumar Budhraja

 

7000

 

 

 

TOTAL

 

301000

 

AS ON 25.09.2012

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Directors or relatives of directors

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing of Various Kind of Pharmaceutical Machines and Formulation of Bulk Drugs etc.

 

 

Products :

                 ITC CODE NO.                

 

PRODUCT DESCRIPTION

29297

Extruder Pelletizer with Die Roller

29297

Fluid Bed Coater

 

PRODUCTION STATUS [AS ON 31.03.2012]

 

Licensed Capacity: The company is not registered under Industrial Development Act, 1961 and hence not required to get sanction for capacity to manufacture.

 

Installed Capacity: The company is carrying out manufacturing of various kind of pharmaceutical machines and formulation of bulk drugs etc. as per individual requirement of the parties and hence installed capacity in respect of these items cannot be ascertained, as stated by the directors.

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

  • Bassein Catholic Co-operative Bank Limited, Manikpur Branch, Vasai, Mumbai – 401201, Maharashtra, India
  • Syndicate Bank, Mumbai, Maharashtra, India
  • Axis Bank , Branch Vasai, Mumbai, Maharashtra, India
  • Kotak Mahindra Bank
  • ICICI Bank
  • State Bank of India

 

 

Facilities :

Secured Loan

As on 31.03.2012

[Rs. in Millions]

As on 31.03.2011

[Rs. in Millions]

Long Term Borrowings

 

 

Term Loans

46.429

68.110

 

 

 

Short Term Borrowings

 

 

Loans Repayable on Demand

 

 

From Banks

9.803

16.300

TOTAL

56.232

84.410

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Pankaj A. Shah and Company

Chartered Accountants

Address :

3/1225, L, Navjivan Comm. Premises Co-operative Society Limited, Lamington Road, Mumbai- 400008, Maharashtra, India

Tel. No.:

91-22-23074148/ 28331135

Fax No.:

91-22-23053478

PAN No:

ABEPS6263J

 

 

Associates/Subsidiaries :

·         R.R. Enterprises

·         Caleva Process Solutions Limited, UK

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

1000000

Equity Shares

Rs.100/- each

Rs.100.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

301000

Equity Shares

Rs.100/- each

Rs.30.100 Millions

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

30.100

30.100

(b) Reserves & Surplus

 

65.880

53.985

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

95.980

84.085

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

67.485

75.916

(b) Deferred tax liabilities (Net)

 

0.000

0.000

(c) Other long term liabilities

 

0.000

0.000

(d) long-term provisions

 

0.000

0.000

Total Non-current Liabilities (3)

 

67.485

75.916

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

9.803

16.300

(b) Trade payables

 

16.552

21.816

(c) Other current liabilities

 

2.600

2.243

(d) Short-term provisions

 

3.174

8.401

Total Current Liabilities (4)

 

32.129

48.760

 

 

 

 

TOTAL

 

195.594

208.761

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

89.713

100.314

(ii) Intangible Assets

 

0.000

0.000

(iii) Capital work-in-progress

 

0.000

0.000

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

42.043

42.043

(c) Deferred tax assets (net)

 

0.815

0.382

(d) Long-term Loan and Advances

 

3.307

5.961

(e) Other Non-current assets

 

0.000

0.000

Total Non-Current Assets

 

135.878

148.700

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

28.607

32.198

(c) Trade receivables

 

22.546

20.025

(d) Cash and cash equivalents

 

1.027

1.271

(e) Short-term loans and advances

 

5.759

6.382

(f) Other current assets

 

1.777

0.185

Total Current Assets

 

59.716

60.061

 

 

 

 

TOTAL

 

195.594

208.761

 

 

SOURCES OF FUNDS

 

 

 

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

30.100

2] Share Application Money

 

 

0.000

3] Reserves & Surplus

 

 

32.144

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

62.244

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

93.479

2] Unsecured Loans

 

 

2.550

TOTAL BORROWING

 

 

96.029

DEFERRED TAX LIABILITIES

 

 

0.000

 

 

 

 

TOTAL

 

 

158.273

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

105.351

Capital work-in-progress

 

 

0.000

 

 

 

 

INVESTMENT

 

 

42.043

DEFERREX TAX ASSETS

 

 

0.021

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

 

68.767

 

Sundry Debtors

 

 

33.292

 

Cash & Bank Balances

 

 

0.258

 

Other Current Assets

 

 

0.000

 

Loans & Advances

 

 

21.077

Total Current Assets

 

 

123.394

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

 

 

 

Other Current Liabilities

 

 

111.541

 

Provisions

 

 

1.139

Total Current Liabilities

 

 

112.680

Net Current Assets

 

 

10.714

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.144

 

 

 

 

TOTAL

 

 

158.273

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Income

 

 

 

 

Other Income

 

 

 

 

 

TOTAL                                     (A)

113.025

187.199

114.108

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

 

 

 

 

Administrative Expenses

73.940

129.749

81.161

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                     (B)

73.940

129.749

81.161

 

 

 

 

 

Less

PROFIT / (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

39.085

57.450

32.947

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

10.024

10.545

10.255

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                (E)

29.061

46.905

22.692

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

12.064

13.100

13.322

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX (E-F)                (G)

16.997

33.805

9.370

 

 

 

 

 

Less

TAX                                                                  (H)

4.925

11.964

3.315

 

 

 

 

 

 

PROFIT / (LOSS) AFTER TAX (G-H)                  (I)

12.072

21.841

6.055

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

53.985

32.144

26.089

 

 

 

 

 

Less

TAXES OF EARLIER YEARS

0.177

0.000

0.000

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

65.880

53.985

32.144

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

2.765

15.834

42.650

 

 

 

 

 

 

IMPORTS

1.664

5.249

6.590

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

4.01

72.56

20.12

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

10.69

11.67

5.30

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

11.13

20.32

4.09

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.17

0.40

0.15

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.81

1.10

1.54

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.85

1.23

1.09

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

PAN of Proprietor/Partner/Director, if available

No

32]

Date of Birth of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

Unsecured Loan

As on 31.03.2012

[Rs. in Millions]

As on 31.03.2011

[Rs. in Millions]

Long Term Borrowings

 

 

Deposits

15.000

3.000

Loans and Advances From Related Parties

6.056

4.806

TOTAL

21.056

7.806

 

 

FINANCIAL RESULTS:

 

Overall Net Sales registered a 42.94% decrease to Rs.106.200 Millions compared to Rs. 180.600 Millions for F.Y.2010-11. This is attributable to global recession in the industries in case of Pharmaceutical Machinery. However new line of pharma products was well received in the global market and company is very optimistic for the years to come. Also company is in continuous in the process of development of new pharma products.

 

Net Profit before tax at Rs.16.997 Millions was 49.78% lower in comparison to F.Y.2010-11. Decrease in Depreciation and amortization at Rs.12.064 Millions over Rs.13.110 Millions last year. Financial Cost showed a decrease of 4.94% compared to last year.

 

PROJECTS:

 

Due to the acquisition of the company proceeding to the earlier financial year in U.K., their company was placed in a better position in the international market as the competition was reduced and their company has shown an extra ordinary performance resulting in to better prospects and profitability in the global as well as Indian market Also company received dividends from the subsidiary during the year. The company has still to acquire more companies for expansion of the business and company's in house research also showed the satisfactory performance for the new line of products introduced mainly being health products, cosmetics etc.

 

 

BANKERS CHARGES REPORT AS PER REGISTRY

 

This form is for

Modification of charge

Charge identification number of the modified 

80044274

Corporate identity number of the company

U29297MH1992PTC066815

Name of the company

UMANG PHARMATECH PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

Flat No. 34, 3rd Floor, B- 2 , Windemere, Off New Link Road, Andheri  (West), Mumbai  - 400 053, Maharashtra, India

Type of charge

Immovable Property

Particular of charge holder

Bassein Catholic Co-operative Bank Limited, Manikpur Branch, Vasai, Mumbai – 401201, Maharashtra, India

Email: amittrivedics@gmail.com

Nature of description of the instrument creating or modifying the charge

Equitable Mortgage Deed.

Date of instrument Creating the charge

06.01.2013

Amount secured by the charge

Rs.70.544 Millions

Brief particulars of the principal terms an conditions and extent and operation of the charge

Rate of Interest

As per then sanction letter ref No BCC/HO/SON/95-2678 Dated 27/12/2012

 

Terms of Repayment

As per then sanction letter ref No BCC/HO/SON/95-2678 Dated 27/12/2012

 

Margin

As per then sanction letter ref No BCC/HO/SON/95-2678 Dated 27/12/2012

 

Extent and Operation of the charge

This additional term loan is sanction for renovation of premises.

Short particulars of the property charged

1) Plot of land bearing survey no 146, Hissa No pt(part) admeasuring 32.6 Gunthas situated village Pelhar, Tal Vasai, and District Thane.    2) Plot of land bearing survey no 146, Hissa No pt (part) admeasuring 48.8 Gunthas situated village Pelhar, Tal Vasai, and District Thane .both the land having boundaries as follows. On or towards the East -- S No 38 owned by vendor, on to towards the West

 

Remaining 26 Gunthas of land S No 146/part. on or towards the south   Dattani Industries.  On or towards the North - 30 ft Road and Makwana farm compound along with factory building constructed thereon admeasuring 20712 sq ft. and research and Development bldg admg 13032 sq ft. within the limits of Grampanchayat pelhar and within the registration Sub District of Vasai 3 of registration district thane.

Date of latest modification prior to the present modification

03.07.2009

Particulars of the present modification 

Now by this modification the bank at the request of the company have decided to grant an additional term loan of Rs 9.044 Millions for renovation of premises. Therefore the total limit now stands increased to Rs 70.544 Millions and to secure the enhanced credit facilities of Rs 9.044 Millions company offered its immovable property.

 

 

FIXED ASSETS:

 

·         Land

·         Factory Premises

·         Furniture and Fixtures

·         Laboratory Equipments

·         Computer

·         Car

·         Air Conditioners

·         Plant and Machinery

·         Fax machine

·         Fire Safety Equipment

·         Dies and Moulds

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.59.35

UK Pound

1

Rs.92.11

Euro

1

Rs.78.59

 

 

INFORMATION DETAILS

 

Report Prepared by :

TPT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

6

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

51

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.